selected publications
-
CAR T cell therapy for multiple myeloma: where are we now and where are we headed?.
Leukemia & lymphoma.
2017
Review
GET IT
Times cited: 42 -
Stop and go: hematopoietic cell transplantation in the era of chimeric antigen receptor T cells and checkpoint inhibitors.
Current opinion in oncology.
2017
Review
GET IT
Times cited: 10 -
Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease.
Immunity.
2012
Academic Article
GET IT
Times cited: 444 -
Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation.
The Journal of experimental medicine.
2012
Academic Article
GET IT
Times cited: 466 -
Interleukin-22 drives endogenous thymic regeneration in mice.
Science (New York, N.Y.).
2012
Academic Article
GET IT
Times cited: 277